Manatuck Hill Partners, LLC Renalytix PLC Transaction History

Manatuck Hill Partners, LLC

  • $230 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$13.43 - $27.4 $288,745 - $589,100
-21,500 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$17.91 - $34.78 $385,065 - $747,770
-21,500 Reduced 50.0%
21,500 $431,000
Q3 2020

Nov 16, 2020
BUY
$10.18 - $17.3 $437,740 - $743,900
43,000 New
43,000 $524,000

Others Institutions Holding RNLX

# of Institutions
29
Shares Held
3.91M
Call Options Held
13.7K
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Manatuck Hill Partners, LLC Portfolio

Follow Manatuck Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manatuck Hill Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email